A phase II study of pembrolizumab combination with temozolomide as 1L treatment for Chinese metastatic acral melanoma patients

被引：0
|
作者：
Ding, Y. [1 ]
Xu, Y. [2 ]
Zhang, X. [1 ]
Chen, Y. [2 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Biotherapy, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
[2] Fudan Univ, Dept Musculoskeletal Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1131P
引用
收藏
页码：S743 / S743
页数：1
相关论文
共 50 条
  • [21] Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma
    John P. Fruehauf
    Monica El-Masry
    Katherine Osann
    Basmina Parmakhtiar
    Maki Yamamoto
    James G. Jakowatz
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 353 - 360
  • [22] The Combination of Radiotherapy with Pembrolizumab in the Treatment of Metastatic Melanoma Patients: a Systematic Review
    Sayyedeh Mahboubeh Anahid
    Omid Afra
    SN Comprehensive Clinical Medicine, 2020, 2 (4) : 432 - 438
  • [23] Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial
    Wierzbicka-Hainaut, Ewa
    Sassolas, Bruno
    Mourey, Laurent
    Guillot, Bernard
    Bedane, Christophe
    Guillet, Gerard
    Tourani, Jean Marc
    MELANOMA RESEARCH, 2010, 20 (02) : 141 - 146
  • [24] A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma
    Pettijohn, Erin
    Martone, Brenda
    Rademaker, Alfred
    Kuzel, Timothy
    JOURNAL OF PERSONALIZED MEDICINE, 2014, 4 (04) : 448 - 458
  • [25] Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
    Tawbi, H. A.
    Beumer, J. H.
    Tarhini, A. A.
    Moschos, S.
    Buch, S. C.
    Egorin, M. J.
    Lin, Y.
    Christner, S.
    Kirkwood, J. M.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 1112 - 1119
  • [26] A Phase I study of temozolomide and carboplatin in patients with metastatic melanoma
    Strauss, SJ
    Marples, M
    Meyer, T
    Napier, M
    Boxall, J
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
  • [27] A phase II study of fruquintinib in the 1L or 2L treatment of unresectable metastatic soft tissue sarcoma
    Luo, Z.
    Zhang, X.
    Zhao, T.
    Zheng, B.
    Yan, W.
    Chen, Y.
    Xu, Y.
    Wang, C.
    Zhang, J.
    Wang, J.
    Yu, L.
    Liu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S1042 - S1042
  • [28] Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study
    Ferrucci, Pier F.
    Minchella, Ida
    Mosconi, Massimo
    Gandini, Sara
    Verrecchia, Francesco
    Cocorocchio, Emilia
    Passoni, Claudia
    Pari, Chiara
    Testori, Alessandro
    Coco, Paola
    Munzone, Elisabetta
    MELANOMA RESEARCH, 2015, 25 (03) : 239 - 245
  • [29] A phase II study of oral azacitidine (CC-486) in combination with pembrolizumab (PEMBRO) in patients (pts) with metastatic melanoma (MM).
    Burton, Elizabeth M.
    Woody, Timothy
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Keung, Emily Zhi-Yun
    Diab, Adi
    Patel, Sapna Pradyuman
    Wong, Michael K. K.
    Yee, Cassian
    Hwu, Patrick
    McQuade, Jennifer Leigh
    Woodman, Scott Eric
    Tetzlaff, Michael T.
    Davies, Michael A.
    Wargo, Jennifer Ann
    Rai, Kunal
    Tawbi, Hussein Abdul-Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma
    Buchbinder, Elizabeth I.
    Sosman, Jeffrey A.
    Lawrence, Donald P.
    McDermott, David F.
    Ramaiya, Nikhil H.
    Van den Abbeele, Annick D.
    Linette, Gerald P.
    Giobbie-Hurder, Anita
    Hodi, F. Stephen
    CANCER, 2015, 121 (22) : 4007 - 4015
12345